Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/11/2017
SIETES contiene 92128 citas

 
 
 1 a 20 de 3586 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Bromley RL, Weston J, Marson AG. Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 2017;318:1700-1. [Ref.ID 102140]
2. Cita con resumen
Crowther CA, Middleton PF, Voysey M, Askie L, Duley L, Pryde PG, Marret S, Doyle LW, for the AMICABLE Group. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis. PLOS Medicine 2017:4 de octubre. [Ref.ID 102113]
3. Cita con resumen
Dathe K, Padberg S, Hultzsch S, Meixner K, Tissen-Diabaté T, Meister R, Beck E, Schaefer C. Metamizole use during first trimester— A prospective observational cohort study on pregnancy outcome. Pharmacoepidemiol Drug Saf 2017;26:1197-204. [Ref.ID 102085]
4. Cita con resumen
Cantarutti A, Merlino L, Giaquinto C, Corrago G. Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population-based investigation. Pharmacoepidemiol Drug Saf 2017;26:1100-8. [Ref.ID 102066]
5. Cita con resumen
Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12. Vaccine 2017;35:5314-22. [Ref.ID 102049]
6. Cita con resumen
Rai D, Lee BK, Dalman C, Newschaffer C, Lewis G, Magnusson C. Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ 2017;358:j2811. [Ref.ID 101979]
7. Cita con resumen
Bérard A, Sheehy O, Zhao J-P, Vinet É, Bernatsky S, Abrahamowicz M. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. Br J Clin Pharmacol 2017;83:1126-33. [Ref.ID 101973]
8. Cita con resumen
Skovlund E, Handal M, Selmer R, Brandlistuen RE, Skurtveit S. Language competence and communication skills in 3-year-old children after prenatal exposure to analgesic opioids. Pharmacoepidemiol Drug Saf 2017;26:625-34. [Ref.ID 101962]
9. Cita con resumen
Taylor LG, Bird ST, Sahin L, Tassinari MS, Greene P, Reichman ME, Andrade SE, Haffenreffer K, Toh S. Antiemetic use among pregnant women in the United States: the escalating use of ondansetron. Pharmacoepidemiol Drug Saf 2017;26:592-6. [Ref.ID 101960]
10. Cita con resumen
Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, Cohen LS, Hernández-Díaz S. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 2017;376:2245-54. [Ref.ID 101629]
11.Enlace a cita original Cita con resumen
Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, Lau WCY, Schuemie MJ, Sturkenboom MCJM, Wong ICK. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study. BMJ 2017;357:j2350. [Ref.ID 101616]
12. Cita con resumen
Nembhard WN, Tang X, Hu Z, MacLeod S, Stowe Z, Webber D, the National Birth Defects Prevention Study. Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study. BMJ 2017;356:j832. [Ref.ID 101588]
13. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
14. Cita con resumen
Sujan AC, Rickert ME, Öberg AS, Quinn PD, Hernández-Díaz S, Almqvist C, Lichtenstein P, Larsson H, D'Onofrio BM. Association of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA 2017;317:1553-62. [Ref.ID 101557]
15. Cita con resumen
Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. Can Med Assoc J 2017;189:E625-33. [Ref.ID 101551]
16. Cita con resumen
Anónimo. Malformations congénitales chez les enfants exposés in utero au valproate et aux autres traitements de l’épilepsie et des troubles bipolaires - Communiqué. Agence nationale de securité du médicament et des produits de santé 2017:20 de abril. [Ref.ID 101537]
17.Enlace a cita original Cita con resumen
Shen Z-Q, Gao S-Y, Li SX, Zhang T-N, Liu C-X, Lv H-C, Zhang Y, Gong T-T, Xu X, Ji C, Wu Q-J, Li D. Sertraline use in the first trimester and risk of congenital anomalies: a systematic review and meta-analysis of cohort studies. Br J Clin Pharmacol 2017;83:909-22. [Ref.ID 101518]
18.Enlace a cita original Cita con resumen
Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernández-Díaz S, Park Y, Dejene SZ, Cohen J, Mogun H, Kim SC. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ 2017;356:j895. [Ref.ID 101510]
19.Enlace a cita original Cita con resumen
Graner S, Svensson T, Beau A-B, Damase-Michel C, Engeland A, Furu K, Hviid A, Haberg SE, Molgaard-Nielsen D, Pasternak B, Kieler H. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. BMJ 2017;356:j629. [Ref.ID 101465]
20. Cita con resumen
Alijotas-Reig J, Esteve-Valverde E. Embarazo y enfermedades autoinmunitarias. Med Clin (Barc) 2017;148:161-3. [Ref.ID 101400]
Seleccionar todas
 
 1 a 20 de 3586 siguiente >>